Madrigal Pharmaceuticals Ownership 2024 | Who Owns Madrigal Pharmaceuticals Now?
Institutional Ownership
32.90%
Insider Ownership
15.17%
Retail Ownership
51.93%
Institutional Holders
155.00
Madrigal Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.16% | 0.38% | 2,601,282 | -300,768 | -10.36% | 694,526,099 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 9.97% | 6.60% | 1,969,798 | - | - | 526,014,858 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 9.84% | 6.06% | 1,944,444 | 55,556 | 2.94% | 519,244,326 | Mar 31, 2024 |
| PAULSON & CO. INC. | 8.98% | 32.74% | 1,775,000 | 669,259 | 60.53% | 473,996,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 8.45% | 0.01% | 1,668,806 | 94,064 | 5.97% | 445,637,954 | Mar 31, 2024 |
| BLACKROCK INC. | 6.13% | 0.01% | 1,210,391 | -2,171 | -0.18% | 323,222,813 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.06% | 0.03% | 803,213 | 414,484 | 106.63% | 214,491,000 | Mar 31, 2024 |
| FMR LLC | 3.61% | 0.01% | 713,914 | 88,749 | 14.20% | 190,643,595 | Mar 31, 2024 |
| STATE STREET CORP | 3.16% | 0.01% | 624,938 | -75,801 | -10.82% | 166,883,444 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.18% | 0.02% | 430,500 | 430,500 | 100.00% | 114,960,720 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.18% | 1.99% | 429,953 | 278,802 | 184.45% | 114,814,649 | Mar 31, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.03% | 0.16% | 401,709 | 105,229 | 35.49% | 107,272,371 | Mar 31, 2024 |
| RTW INVESTMENTS, LP | 2.01% | 1.57% | 397,047 | -418,144 | -51.29% | 106,027,431 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.76% | 0.01% | 346,857 | 10,602 | 3.15% | 92,638,421 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.69% | 0.02% | 333,800 | 333,800 | 100.00% | 89,137,952 | Mar 31, 2024 |
| MORGAN STANLEY | 1.46% | 0.01% | 288,606 | 136,688 | 89.97% | 77,069,442 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.45% | 1.94% | 285,931 | 87,762 | 44.29% | 76,355,014 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 1.03% | 0.08% | 204,500 | - | - | 54,609,680 | Mar 31, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.00% | 4.23% | 196,995 | -127,624 | -39.31% | 52,605,545 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.93% | 0.05% | 184,163 | 12,998 | 7.59% | 48,426,921 | Mar 31, 2024 |
Madrigal Pharmaceuticals's largest institutional shareholder is JANUS HENDERSON GROUP PLC, holding 13.16% of the company's total share outstanding, currently valued at $694.53M. The top 10 institutional shareholders own together 69.54% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TAO CAPITAL MANAGEMENT LP | 0.66% | 33.02% | 130,529 | - | - | 34,856,464 | Mar 31, 2024 |
| PAULSON & CO. INC. | 8.98% | 32.74% | 1,775,000 | 669,259 | 60.53% | 473,996,000 | Mar 31, 2024 |
| UNIVERSITY OF WISCONSIN FOUNDATION | 0.29% | 16.99% | 56,376 | -17,111 | -23.28% | 15,054,647 | Mar 31, 2024 |
| ALPINVEST PARTNERS B.V. | 0.54% | 11.03% | 105,744 | -105,744 | -50.00% | 28,237,878 | Mar 31, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.22% | 6.69% | 43,032 | 13,000 | 43.29% | 11,491,265 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 9.97% | 6.60% | 1,969,798 | - | - | 526,014,858 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 9.84% | 6.06% | 1,944,444 | 55,556 | 2.94% | 519,244,326 | Mar 31, 2024 |
| TRI LOCUM PARTNERS LP | 0.27% | 4.94% | 53,355 | 27,831 | 109.04% | 14,247,919 | Mar 31, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.00% | 4.23% | 196,995 | -127,624 | -39.31% | 52,605,545 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.26% | 4.06% | 51,000 | 51,000 | 100.00% | 13,619,040 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.58% | 3.80% | 115,000 | 15,000 | 15.00% | 30,709,600 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.90% | 3.48% | 177,900 | 167,900 | 1679.00% | 47,506,416 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.76% | 3.15% | 149,283 | -30,634 | -17.03% | 39,864,532 | Mar 31, 2024 |
| BIOIMPACT CAPITAL LLC | 0.31% | 2.64% | 61,399 | 20,489 | 50.08% | 16,395,989 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.18% | 1.99% | 429,953 | 278,802 | 184.45% | 114,814,649 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.45% | 1.94% | 285,931 | 87,762 | 44.29% | 76,355,014 | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.04% | 1.81% | 7,900 | -5,302 | -40.16% | 2,109,616 | Mar 31, 2024 |
| RTW INVESTMENTS, LP | 2.01% | 1.57% | 397,047 | -418,144 | -51.29% | 106,027,431 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.26% | 1.50% | 51,400 | 51,400 | 100.00% | 13,725,856 | Mar 31, 2024 |
| RHEOS CAPITAL WORKS INC. | 0.56% | 1.41% | 110,215 | 110,215 | 100.00% | 29,432,000 | Mar 31, 2024 |
The largest Madrigal Pharmaceuticals shareholder by % of total assets is TAO CAPITAL MANAGEMENT LP. The company owns 130.53K shares of Madrigal Pharmaceuticals (MDGL), representing 33.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PAULSON & CO. INC. | 8.98% | 32.74% | 1,775,000 | 669,259 | 60.53% | 473,996,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.18% | 0.02% | 430,500 | 430,500 | 100.00% | 114,960,720 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.06% | 0.03% | 803,213 | 414,484 | 106.63% | 214,491,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.69% | 0.02% | 333,800 | 333,800 | 100.00% | 89,137,952 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.18% | 1.99% | 429,953 | 278,802 | 184.45% | 114,814,649 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.90% | 3.48% | 177,900 | 167,900 | 1679.00% | 47,506,416 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.76% | 0.10% | 150,000 | 150,000 | 100.00% | 40,056,000 | Mar 31, 2024 |
| MORGAN STANLEY | 1.46% | 0.01% | 288,606 | 136,688 | 89.97% | 77,069,442 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 0.63% | 0.18% | 125,205 | 125,205 | 100.00% | 33,434,743 | Mar 31, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.62% | 0.07% | 122,200 | 122,200 | 100.00% | 32,632,289 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 0.85% | 0.59% | 168,000 | 118,000 | 236.00% | 44,862,720 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 0.56% | 0.75% | 110,507 | 110,507 | 100.00% | 29,509,789 | Mar 31, 2024 |
| RHEOS CAPITAL WORKS INC. | 0.56% | 1.41% | 110,215 | 110,215 | 100.00% | 29,432,000 | Mar 31, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.03% | 0.16% | 401,709 | 105,229 | 35.49% | 107,272,371 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 0.49% | 0.09% | 97,103 | 97,103 | 100.00% | 25,931,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 8.45% | 0.01% | 1,668,806 | 94,064 | 5.97% | 445,637,954 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.47% | 0.06% | 93,571 | 93,571 | 100.00% | 24,987,200 | Mar 31, 2024 |
| FMR LLC | 3.61% | 0.01% | 713,914 | 88,749 | 14.20% | 190,643,595 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.45% | 1.94% | 285,931 | 87,762 | 44.29% | 76,355,014 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 0.38% | 0.51% | 75,000 | 75,000 | 100.00% | 20,028,000 | Mar 31, 2024 |
As of Mar 31 2024, Madrigal Pharmaceuticals's largest institutional buyer is PAULSON & CO. INC.. The company purchased 669.26K stocks of MDGL, valued at $474.00M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 2.01% | 1.57% | 397,047 | -418,144 | -51.29% | 106,027,431 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.14% | 0.00% | 27,900 | -311,854 | -91.79% | 7,450,416 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 13.16% | 0.38% | 2,601,282 | -300,768 | -10.36% | 694,526,099 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | - | - | - | -280,000 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.13% | 0.00% | 25,151 | -191,667 | -88.40% | 6,716,323 | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | 0.22% | 0.04% | 43,171 | -148,760 | -77.51% | 11,528,384 | Mar 31, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.00% | 4.23% | 196,995 | -127,624 | -39.31% | 52,605,545 | Mar 31, 2024 |
| ALPINVEST PARTNERS B.V. | 0.54% | 11.03% | 105,744 | -105,744 | -50.00% | 28,237,878 | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | - | - | - | -82,287 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | 3.16% | 0.01% | 624,938 | -75,801 | -10.82% | 166,883,444 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | - | - | - | -69,406 | -100.00% | - | Mar 31, 2024 |
| L1 CAPITAL PTY LTD | - | - | - | -50,230 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | 0.09% | 0.00% | 16,811 | -42,974 | -71.88% | 4,489,137,000 | Mar 31, 2024 |
| MARSHALL WACE, LLP | - | - | - | -33,071 | -100.00% | - | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.76% | 3.15% | 149,283 | -30,634 | -17.03% | 39,864,532 | Mar 31, 2024 |
| LMR PARTNERS LLP | 0.11% | 0.06% | 22,108 | -29,777 | -57.39% | 5,903,720 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -27,767 | -100.00% | - | Mar 31, 2024 |
| ROSALIND ADVISORS, INC. | - | - | - | -25,000 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -20,444 | -100.00% | - | Mar 31, 2024 |
| CUTLER GROUP LLC / CA | 0.19% | 0.36% | 36,900 | -19,300 | -34.34% | 1,092,000 | Mar 31, 2024 |
As of Mar 31 2024, Madrigal Pharmaceuticals's biggest institutional seller is RTW INVESTMENTS, LP. The company sold -0.42M shares of MDGL, valued at $106.03M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.18% | 0.02% | 430,500 | 430,500 | 100.00% | 114,960,720 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.69% | 0.02% | 333,800 | 333,800 | 100.00% | 89,137,952 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.76% | 0.10% | 150,000 | 150,000 | 100.00% | 40,056,000 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 0.63% | 0.18% | 125,205 | 125,205 | 100.00% | 33,434,743 | Mar 31, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.62% | 0.07% | 122,200 | 122,200 | 100.00% | 32,632,289 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 0.56% | 0.75% | 110,507 | 110,507 | 100.00% | 29,509,789 | Mar 31, 2024 |
| RHEOS CAPITAL WORKS INC. | 0.56% | 1.41% | 110,215 | 110,215 | 100.00% | 29,432,000 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 0.49% | 0.09% | 97,103 | 97,103 | 100.00% | 25,931,000 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 0.38% | 0.51% | 75,000 | 75,000 | 100.00% | 20,028,000 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.26% | 1.50% | 51,400 | 51,400 | 100.00% | 13,725,856 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.26% | 4.06% | 51,000 | 51,000 | 100.00% | 13,619,040 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.26% | 0.13% | 50,709 | 50,709 | 100.00% | 13,541,331 | Mar 31, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.22% | 0.03% | 43,800 | 43,800 | 100.00% | 11,696,352 | Mar 31, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 0.22% | 0.01% | 42,986 | 42,986 | 100.00% | 11,479,000 | Mar 31, 2024 |
| GILDER GAGNON HOWE & CO LLC | 0.20% | 0.13% | 39,083 | 39,083 | 100.00% | 10,436,724 | Mar 31, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 0.19% | 0.05% | 37,762 | 37,762 | 100.00% | 10,063,951 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.17% | 0.10% | 34,219 | 34,219 | 100.00% | 9,137,842 | Mar 31, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.15% | 0.02% | 30,297 | 30,297 | 100.00% | 8,090,511 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.15% | 0.02% | 30,050 | 30,050 | 100.00% | 7,684,987,000 | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 0.15% | 0.38% | 29,973 | 29,973 | 100.00% | 8,003,990 | Mar 31, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.13% | 0.76% | 25,000 | 25,000 | 100.00% | 6,676,000 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.10% | 0.05% | 19,700 | 19,700 | 100.00% | 5,260,688 | Mar 31, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.10% | 0.28% | 19,029 | 19,029 | 100.00% | 5,081,504 | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | 0.01% | 15,000 | 15,000 | 100.00% | 4,005,600 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.08% | 14,800 | 14,800 | 100.00% | 3,952,192 | Mar 31, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.07% | 0.71% | 13,319 | 13,319 | 100.00% | 3,556,706 | Mar 31, 2024 |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 0.06% | 1.29% | 11,033 | 11,033 | 100.00% | 2,946,252 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 10,560 | 10,560 | 100.00% | 2,819,942 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.05% | 0.01% | 10,000 | 10,000 | 100.00% | 2,670,400 | Mar 31, 2024 |
| CASTLEARK MANAGEMENT LLC | 0.05% | 0.10% | 9,210 | 9,210 | 100.00% | 2,459,438 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.05% | 0.00% | 9,100 | 9,100 | 100.00% | 2,430,064 | Mar 31, 2024 |
| BARCLAYS PLC | 0.05% | 0.00% | 9,000 | 9,000 | 100.00% | 2,403,000 | Mar 31, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.02% | 0.01% | 4,000 | 4,000 | 100.00% | 1,068,160 | Mar 31, 2024 |
| CALAMOS ADVISORS LLC | 0.02% | 0.00% | 3,613 | 3,613 | 100.00% | 964,816 | Mar 31, 2024 |
| SHEAFF BROCK INVESTMENT ADVISORS, LLC | 0.02% | 0.06% | 3,600 | 3,600 | 100.00% | 961,344 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.01% | 0.00% | 2,200 | 2,200 | 100.00% | 587,488 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.01% | 0.03% | 2,186 | 2,186 | 100.00% | 583,749 | Mar 31, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.01% | 0.33% | 2,075 | 2,075 | 100.00% | 554,000 | Mar 31, 2024 |
| SOROS FUND MANAGEMENT LLC | 0.01% | 0.01% | 2,016 | 2,016 | 100.00% | 538,353 | Mar 31, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.01% | 1,800 | 1,800 | 100.00% | 480,672 | Mar 31, 2024 |
| PARKWOOD LLC | 0.01% | 0.04% | 1,782 | 1,782 | 100.00% | 476,000 | Mar 31, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.01% | 0.08% | 1,557 | 1,557 | 100.00% | 415,781 | Mar 31, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.01% | 0.00% | 1,502 | 1,502 | 100.00% | 401,094 | Mar 31, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 1,500 | 1,500 | 100.00% | 400,560 | Mar 31, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | 0.01% | 0.02% | 1,499 | 1,499 | 100.00% | 400,293 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 0.01% | 0.00% | 1,414 | 1,414 | 100.00% | 377,594 | Mar 31, 2024 |
| OPPENHEIMER & CO INC | 0.01% | 0.01% | 1,220 | 1,220 | 100.00% | 325,789 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.01% | 0.00% | 1,200 | 1,200 | 100.00% | 320,448 | Mar 31, 2024 |
| CONGRESS PARK CAPITAL LLC | 0.01% | 0.14% | 1,200 | 1,200 | 100.00% | 320,448 | Mar 31, 2024 |
| CERITY PARTNERS LLC | 0.01% | 0.00% | 1,142 | 1,142 | 100.00% | 304,960 | Mar 31, 2024 |
| OVERBROOK MANAGEMENT CORP | 0.01% | 0.08% | 1,130 | 1,130 | 100.00% | 301,755 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 1,093 | 1,093 | 100.00% | 291,875 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 0.01% | 0.00% | 1,060 | 1,060 | 100.00% | 283,062 | Mar 31, 2024 |
| CETERA ADVISORS LLC | 0.01% | 0.00% | 1,051 | 1,051 | 100.00% | 280,659 | Mar 31, 2024 |
| PITCAIRN CO | 0.01% | 0.02% | 1,007 | 1,007 | 100.00% | 268,909 | Mar 31, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 267,040 | Mar 31, 2024 |
| CENTIVA CAPITAL, LP | 0.01% | 0.01% | 1,000 | 1,000 | 100.00% | 267,040 | Mar 31, 2024 |
| SWEET FINANCIAL PARTNERS, LLC | 0.01% | 0.06% | 1,000 | 1,000 | 100.00% | 267,040 | Mar 31, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.00% | 0.00% | 973 | 973 | 100.00% | 259,830 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.00% | 0.00% | 954 | 954 | 100.00% | 255,000 | Mar 31, 2024 |
| SASSICAIA CAPITAL ADVISERS LLC | 0.00% | 1.02% | 900 | 900 | 100.00% | 240,336 | Mar 31, 2024 |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 0.00% | 0.11% | 875 | 875 | 100.00% | 233,660 | Mar 31, 2024 |
| PFG INVESTMENTS, LLC | 0.00% | 0.01% | 858 | 858 | 100.00% | 229,120 | Mar 31, 2024 |
| MACKENZIE FINANCIAL CORP | 0.00% | 0.00% | 799 | 799 | 100.00% | 213,365 | Mar 31, 2024 |
| CETERA ADVISOR NETWORKS LLC | 0.00% | 0.00% | 773 | 773 | 100.00% | 206,422 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | 0.00% | 500 | 500 | 100.00% | 133,520 | Mar 31, 2024 |
| CREATIVE PLANNING | 0.00% | - | 400 | 400 | 100.00% | 3,562 | Mar 31, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 41,730 | Mar 31, 2024 |
| BNP PARIBAS | 0.00% | 0.00% | 255 | 255 | 100.00% | 68,095 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 53,408 | Mar 31, 2024 |
| UMB BANK, N.A. | 0.00% | 0.00% | 200 | 200 | 100.00% | 53,408 | Mar 31, 2024 |
| CLEAR STREET MARKETS LLC | 0.00% | 0.01% | 200 | 200 | 100.00% | 53,000 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | 0.00% | 170 | 170 | 100.00% | 45,397 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.04% | 155 | 155 | 100.00% | 41,391 | Mar 31, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 90 | 90 | 100.00% | 24,033 | Mar 31, 2024 |
| COMPAGNIE LOMBARD ODIER SCMA | 0.00% | 0.00% | 80 | 80 | 100.00% | 21,363 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 29 | 29 | 100.00% | 7,744 | Mar 31, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.00% | 0.00% | 11 | 11 | 100.00% | 2,000 | Mar 31, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 10 | 10 | 100.00% | 2,670 | Mar 31, 2024 |
| ZRC WEALTH MANAGEMENT, LLC | - | 0.00% | 9 | 9 | 100.00% | 2,404,000 | Mar 31, 2024 |
| FARMERS & MERCHANTS TRUST CO OF CHAMBERSBURG PA | - | 0.00% | 8 | 8 | 100.00% | 2,000 | Mar 31, 2024 |
| QUEST PARTNERS LLC | - | 0.00% | 4 | 4 | 100.00% | 1,068 | Mar 31, 2024 |
| WESTEND CAPITAL MANAGEMENT, LLC | - | 0.00% | 4 | 4 | 100.00% | 1,068 | Mar 31, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | 0.00% | 2 | 2 | 100.00% | 535 | Mar 31, 2024 |
| ATLAS CAPITAL ADVISORS LLC | - | - | 1 | 1 | 100.00% | 267 | Mar 31, 2024 |
Madrigal Pharmaceuticals's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 430.50K shares, valued at $114.96M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | - | - | - | -280,000 | -100.00% | - | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | - | - | - | -82,287 | -100.00% | - | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | - | - | - | -69,406 | -100.00% | - | Mar 31, 2024 |
| L1 CAPITAL PTY LTD | - | - | - | -50,230 | -100.00% | - | Mar 31, 2024 |
| MARSHALL WACE, LLP | - | - | - | -33,071 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -27,767 | -100.00% | - | Mar 31, 2024 |
| ROSALIND ADVISORS, INC. | - | - | - | -25,000 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -20,444 | -100.00% | - | Mar 31, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | - | - | - | -15,147 | -100.00% | - | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -12,458 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -10,400 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -9,900 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -9,100 | -100.00% | - | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -7,763 | -100.00% | - | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -5,227 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -4,503 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -3,716 | -100.00% | - | Mar 31, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -2,350 | -100.00% | - | Mar 31, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -2,293 | -100.00% | - | Mar 31, 2024 |
| AXQ CAPITAL, LP | - | - | - | -2,200 | -100.00% | - | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -1,551 | -100.00% | - | Mar 31, 2024 |
| CAPTRUST FINANCIAL ADVISORS | - | - | - | -1,474 | -100.00% | - | Mar 31, 2024 |
| SIERRA SUMMIT ADVISORS LLC | - | - | - | -1,434 | -100.00% | - | Mar 31, 2024 |
| MBB PUBLIC MARKETS I LLC | - | - | - | -1,400 | -100.00% | - | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -1,247 | -100.00% | - | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -1,102 | -100.00% | - | Mar 31, 2024 |
| GLENMEDE TRUST CO NA | - | - | - | -1,066 | -100.00% | - | Mar 31, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -1,000 | -100.00% | - | Mar 31, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -987 | -100.00% | - | Mar 31, 2024 |
| CENTERBOOK PARTNERS LP | - | - | - | -953 | -100.00% | - | Mar 31, 2024 |
| NATIXIS | - | - | - | -857 | -100.00% | - | Mar 31, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
| WIT, LLC | - | - | - | -35 | -100.00% | - | Mar 31, 2024 |
| RONALD BLUE TRUST, INC. | - | - | - | -19 | -100.00% | - | Mar 31, 2024 |
Madrigal Pharmaceuticals's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.28M shares, valued at -, as of undefined.
Madrigal Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 0.42% | 2,970 | - | - | Dec 31, 2023 |
| HARTFORD HLS SERIES FUND II INC | 0.23% | 56,641 | - | - | Dec 31, 2023 |
| Tema ETF Trust | 0.10% | 4,403 | 2,945 | 201.99% | Feb 29, 2024 |
| NEW ECONOMY FUND | 0.09% | 387,221 | - | - | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.05% | 50,627 | -3,038 | -5.66% | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.04% | 61,552 | -14 | -0.02% | Jan 31, 2024 |
| GROWTH FUND OF AMERICA | 0.04% | 923,524 | - | - | Feb 29, 2024 |
| EntrepreneurShares Series Trust | 0.03% | 8,197 | 6,058 | 283.22% | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.03% | 28,500 | - | - | Dec 29, 2023 |
| ALGER FUNDS | 0.03% | 25,103 | 13,886 | 123.79% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 10,230 | - | - | Dec 31, 2023 |
| VIRTUS ALTERNATIVE SOLUTIONS TRUST | 0.01% | 55 | - | - | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.01% | 1,618 | -730 | -31.09% | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.01% | 7,090 | - | - | Dec 31, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 39,037 | 700 | 1.83% | Dec 31, 2023 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.01% | 39,601 | - | - | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.01% | 21,451 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.01% | 10,540 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.01% | 206 | 2 | 0.98% | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.01% | 2,269 | - | - | Dec 31, 2023 |
| VALUE LINE CAPITAL APPRECIATION FUND INC | 0.01% | 13,000 | 13,000 | - | Dec 31, 2023 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.01% | 70,530 | 11,605 | 19.69% | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 428,422 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.01% | 1,999,697 | 366,092 | 22.41% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 53,400 | -18,100 | -25.31% | Jan 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.01% | 2,989 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 2,255 | 195 | 9.47% | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 26,853 | 3,761 | 16.29% | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.00% | 38,900 | 700 | 1.83% | Jan 31, 2024 |
| TOCQUEVILLE TRUST | 0.00% | 500 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,632,991 | 325,522 | 24.90% | Dec 31, 2023 |
| ALLSPRING VARIABLE TRUST | 0.00% | 1,538 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 139,408 | -27,100 | -16.28% | Feb 29, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.00% | 12,039 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 25,105 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 6,490 | 93 | 1.45% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 160,400 | -18,300 | -10.24% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 19,964 | - | - | Feb 29, 2024 |
| Bernstein Fund Inc | 0.00% | 16,300 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 42,903 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.00% | 3,298 | - | - | Jan 31, 2024 |
| JANUS ASPEN SERIES | 0.00% | 51,933 | 14,560 | 38.96% | Dec 31, 2023 |
| T. Rowe Price Equity Funds, Inc. | 0.00% | 20,548 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 275 | - | - | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.00% | 6,454 | - | - | Mar 31, 2020 |
| ROYCE MICRO-CAP TRUST, INC. | 0.00% | 490 | - | - | Dec 31, 2023 |
| HARTFORD SERIES FUND INC | 0.00% | 38,642 | - | - | Dec 31, 2023 |
| ETF Managers Trust | 0.00% | 6,518 | - | - | Dec 31, 2023 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 459 | 99 | 27.50% | Sep 30, 2020 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 3,286 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.00% | 4,832 | - | - | Aug 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 148,964 | 5,483 | 3.82% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 2,735 | 237 | 9.49% | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 1,532 | 179 | 13.23% | Dec 31, 2023 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 2,597 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 4,795 | 2,254 | 88.71% | Jan 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 38,632 | 22,137 | 134.20% | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 344 | -5 | -1.43% | Sep 30, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 82,333 | 3,576 | 4.54% | Feb 29, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 1,691 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 10,726 | 737 | 7.38% | Dec 31, 2023 |
| OLD WESTBURY FUNDS INC | 0.00% | 45,830 | -723 | -1.55% | Jan 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 3,302 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 380 | 30 | 8.57% | Dec 31, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 12,803 | -228 | -1.75% | Dec 31, 2023 |
| KINETICS PORTFOLIOS TRUST | 0.00% | 514 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,028 | - | - | Feb 29, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 35,062 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 41,373 | 5,705 | 15.99% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 352 | -36 | -9.28% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 36,455 | - | - | Jan 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 186,804 | 44,840 | 31.59% | Dec 31, 2023 |
| Forethought Variable Insurance Trust | 0.00% | 852 | - | - | Dec 29, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 758 | - | - | Dec 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 15,777 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,848 | 407 | 7.48% | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 2,556 | 649 | 34.03% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,932 | 977 | 24.70% | Dec 29, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 2,013 | -165 | -7.58% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 39,938 | 3,295 | 8.99% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 714 | 8 | 1.13% | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 3,127 | -42 | -1.33% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,970 | -1,985 | -50.19% | Dec 31, 2023 |
| AMG Funds I | 0.00% | 213 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 72 | - | - | Apr 30, 2021 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.00% | 35,764 | - | - | Dec 31, 2023 |
| PFM Multi-Manager Series Trust | 0.00% | 100 | - | - | Dec 31, 2023 |
| NEW COVENANT FUNDS | 0.00% | 531 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 1,701 | 446 | 35.54% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 105,678 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 4,841 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 221 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 2,208 | - | - | Dec 31, 2023 |
| TIFF INVESTMENT PROGRAM | 0.00% | 3,100 | - | - | Dec 31, 2023 |
| LORD ABBETT SERIES FUND INC | 0.00% | 1,443 | - | - | Dec 31, 2023 |
| Voya INVESTORS TRUST | 0.00% | 3,205 | -148 | -4.41% | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,259 | 1,000 | 23.48% | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 61,709 | 2,129 | 3.57% | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 16,749 | 127 | 0.76% | Jan 31, 2024 |
| VIRTUS ASSET TRUST | 0.00% | 1,213 | - | - | Dec 29, 2023 |
Madrigal Pharmaceuticals's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 2.97K shares, compromising 0.42% of its total assets.
Madrigal Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 155 | -38.74% |
| 31 Dec, 23 | 253 | 11.45% |
| 30 Sep, 23 | 227 | -2.58% |
| 30 Jun, 23 | 233 | -4.12% |
| 31 Mar, 23 | 243 | 13.55% |
| 31 Dec, 22 | 214 | 44.59% |
| 30 Sep, 22 | 148 | -0.67% |
| 30 Jun, 22 | 149 | 2.76% |
| 31 Mar, 22 | 145 | -3.33% |
| 31 Dec, 21 | 150 | 7.14% |
| 30 Sep, 21 | 140 | -8.50% |
| 30 Jun, 21 | 153 | 7.75% |
| 31 Mar, 21 | 142 | 0.71% |
| 31 Dec, 20 | 141 | 1.44% |
| 30 Sep, 20 | 139 | 2.96% |
| 30 Jun, 20 | 135 | 21.62% |
| 31 Mar, 20 | 111 | -13.95% |
| 31 Dec, 19 | 129 | 8.40% |
| 30 Sep, 19 | 119 | -9.85% |
| 30 Jun, 19 | 132 | -12.58% |
| 31 Mar, 19 | 151 | 2.72% |
| 31 Dec, 18 | 147 | -12.50% |
| 30 Sep, 18 | 168 | 9.09% |
| 30 Jun, 18 | 154 | 55.56% |
| 31 Mar, 18 | 99 | 11.24% |
| 31 Dec, 17 | 89 | 78.00% |
| 30 Sep, 17 | 50 | 28.21% |
| 30 Jun, 17 | 39 | 50.00% |
| 31 Mar, 17 | 26 | 4.00% |
| 31 Dec, 16 | 25 | -10.71% |
| 30 Sep, 16 | 28 | - |
As of 31 Mar 24, 155 institutions are holding Madrigal Pharmaceuticals's shares, representing a decrease of -38.74% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 6,500,609 | -66.46% |
| 31 Dec, 23 | 19,381,550 | 14.28% |
| 30 Sep, 23 | 16,959,682 | 15.40% |
| 30 Jun, 23 | 14,696,376 | 7.97% |
| 31 Mar, 23 | 13,611,040 | 2.29% |
| 31 Dec, 22 | 13,306,777 | 13.54% |
| 30 Sep, 22 | 11,719,650 | -2.38% |
| 30 Jun, 22 | 12,005,530 | -1.83% |
| 31 Mar, 22 | 12,229,169 | 2.82% |
| 31 Dec, 21 | 11,893,607 | 8.75% |
| 30 Sep, 21 | 10,936,360 | -2.39% |
| 30 Jun, 21 | 11,204,474 | -8.06% |
| 31 Mar, 21 | 12,186,285 | -0.43% |
| 31 Dec, 20 | 12,239,357 | 5.65% |
| 30 Sep, 20 | 11,585,158 | 2.99% |
| 30 Jun, 20 | 11,249,007 | 2.20% |
| 31 Mar, 20 | 11,006,471 | 5.66% |
| 31 Dec, 19 | 10,416,414 | 8.07% |
| 30 Sep, 19 | 9,638,703 | 0.85% |
| 30 Jun, 19 | 9,556,994 | 1.61% |
| 31 Mar, 19 | 9,405,645 | 10.96% |
| 31 Dec, 18 | 8,476,533 | -1.79% |
| 30 Sep, 18 | 8,630,858 | 6.26% |
| 30 Jun, 18 | 8,122,390 | 28.36% |
| 31 Mar, 18 | 6,327,776 | 23.53% |
| 31 Dec, 17 | 5,122,308 | 91.60% |
| 30 Sep, 17 | 2,673,430 | 30.58% |
| 30 Jun, 17 | 2,047,319 | 34.89% |
| 31 Mar, 17 | 1,517,802 | 12.79% |
| 31 Dec, 16 | 1,345,660 | 33.60% |
| 30 Sep, 16 | 1,007,212 | - |
Madrigal Pharmaceuticals (MDGL) has 6.50M shares outstanding as of 31 Mar 24, down -66.46% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 32.90% | 0.30% |
| 31 Dec, 23 | 104.90% | 1.22% |
| 30 Sep, 23 | 92.62% | 1.42% |
| 30 Jun, 23 | 80.80% | 1.44% |
| 31 Mar, 23 | 74.84% | 1.24% |
| 31 Dec, 22 | 77.65% | 1.65% |
| 30 Sep, 22 | 68.52% | 1.39% |
| 30 Jun, 22 | 70.19% | 1.37% |
| 31 Mar, 22 | 71.50% | 1.47% |
| 31 Dec, 21 | 69.66% | 1.61% |
| 30 Sep, 21 | 65.72% | 1.44% |
| 30 Jun, 21 | 67.61% | 1.14% |
| 31 Mar, 21 | 76.93% | 1.23% |
| 31 Dec, 20 | 79.09% | 1.41% |
| 30 Sep, 20 | 74.99% | 1.41% |
| 30 Jun, 20 | 72.89% | 1.43% |
| 31 Mar, 20 | 71.34% | 1.56% |
| 31 Dec, 19 | 67.66% | 1.73% |
| 30 Sep, 19 | 62.53% | 1.62% |
| 30 Jun, 19 | 62.18% | 1.66% |
| 31 Mar, 19 | 61.22% | 2.01% |
| 31 Dec, 18 | 55.23% | 1.74% |
| 30 Sep, 18 | 56.38% | 1.77% |
| 30 Jun, 18 | 56.47% | 2.81% |
| 31 Mar, 18 | 44.79% | 2.56% |
| 31 Dec, 17 | 41.83% | 8.97% |
| 30 Sep, 17 | 21.60% | 7.47% |
| 30 Jun, 17 | 17.01% | 10.55% |
| 31 Mar, 17 | 12.70% | 9.29% |
| 31 Dec, 16 | 11.69% | 12.61% |
| 30 Sep, 16 | 9.63% | - |
As of 31 Mar 24, Madrigal Pharmaceuticals is held by 32.90% institutional shareholders, representing a 0.30% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 87 | -41.61% |
| 31 Dec, 23 | 149 | 20.16% |
| 30 Sep, 23 | 124 | -3.88% |
| 30 Jun, 23 | 129 | -9.15% |
| 31 Mar, 23 | 142 | -0.70% |
| 31 Dec, 22 | 143 | 95.89% |
| 30 Sep, 22 | 73 | 8.96% |
| 30 Jun, 22 | 67 | 1.52% |
| 31 Mar, 22 | 66 | -10.81% |
| 31 Dec, 21 | 74 | 29.82% |
| 30 Sep, 21 | 57 | -32.94% |
| 30 Jun, 21 | 85 | 25.00% |
| 31 Mar, 21 | 68 | 3.03% |
| 31 Dec, 20 | 66 | 24.53% |
| 30 Sep, 20 | 53 | -27.40% |
| 30 Jun, 20 | 73 | 21.67% |
| 31 Mar, 20 | 60 | -11.76% |
| 31 Dec, 19 | 68 | 4.62% |
| 30 Sep, 19 | 65 | -9.72% |
| 30 Jun, 19 | 72 | -4.00% |
| 31 Mar, 19 | 75 | 2.74% |
| 31 Dec, 18 | 73 | -27.00% |
| 30 Sep, 18 | 100 | -9.09% |
| 30 Jun, 18 | 110 | 64.18% |
| 31 Mar, 18 | 67 | -6.94% |
| 31 Dec, 17 | 72 | 132.26% |
| 30 Sep, 17 | 31 | - |
| 30 Jun, 17 | 31 | 93.75% |
| 31 Mar, 17 | 16 | 45.45% |
| 31 Dec, 16 | 11 | -59.26% |
| 30 Sep, 16 | 27 | - |
87 institutional shareholders have increased their position in MDGL stock as of 31 Mar 24 compared to 149 in the previous quarter (a -41.61% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 39 | -35.00% |
| 31 Dec, 23 | 60 | 7.14% |
| 30 Sep, 23 | 56 | - |
| 30 Jun, 23 | 56 | -11.11% |
| 31 Mar, 23 | 63 | 61.54% |
| 31 Dec, 22 | 39 | 14.71% |
| 30 Sep, 22 | 34 | -17.07% |
| 30 Jun, 22 | 41 | -2.38% |
| 31 Mar, 22 | 42 | 13.51% |
| 31 Dec, 21 | 37 | -5.13% |
| 30 Sep, 21 | 39 | 2.63% |
| 30 Jun, 21 | 38 | -5.00% |
| 31 Mar, 21 | 40 | - |
| 31 Dec, 20 | 40 | -13.04% |
| 30 Sep, 20 | 46 | 35.29% |
| 30 Jun, 20 | 34 | 21.43% |
| 31 Mar, 20 | 28 | -20.00% |
| 31 Dec, 19 | 35 | 40.00% |
| 30 Sep, 19 | 25 | -3.85% |
| 30 Jun, 19 | 26 | -18.75% |
| 31 Mar, 19 | 32 | -31.91% |
| 31 Dec, 18 | 47 | 11.90% |
| 30 Sep, 18 | 42 | 23.53% |
| 30 Jun, 18 | 34 | 41.67% |
| 31 Mar, 18 | 24 | 140.00% |
| 31 Dec, 17 | 10 | 25.00% |
| 30 Sep, 17 | 8 | 166.67% |
| 30 Jun, 17 | 3 | - |
| 31 Mar, 17 | 3 | -25.00% |
| 31 Dec, 16 | 4 | - |
| 30 Sep, 16 | - | - |
39 institutional shareholders have reduced their position in MDGL stock as of 31 Mar 24 compared to 60 in the previous quarter (a -35.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 155 | -38.74% | 6,500,609 | -66.46% | 32.90% | 0.30% | 87 | -41.61% | 39 | -35.00% |
| 31 Dec, 23 | 253 | 11.45% | 19,381,550 | 14.28% | 104.90% | 1.22% | 149 | 20.16% | 60 | 7.14% |
| 30 Sep, 23 | 227 | -2.58% | 16,959,682 | 15.40% | 92.62% | 1.42% | 124 | -3.88% | 56 | - |
| 30 Jun, 23 | 233 | -4.12% | 14,696,376 | 7.97% | 80.80% | 1.44% | 129 | -9.15% | 56 | -11.11% |
| 31 Mar, 23 | 243 | 13.55% | 13,611,040 | 2.29% | 74.84% | 1.24% | 142 | -0.70% | 63 | 61.54% |
| 31 Dec, 22 | 214 | 44.59% | 13,306,777 | 13.54% | 77.65% | 1.65% | 143 | 95.89% | 39 | 14.71% |
| 30 Sep, 22 | 148 | -0.67% | 11,719,650 | -2.38% | 68.52% | 1.39% | 73 | 8.96% | 34 | -17.07% |
| 30 Jun, 22 | 149 | 2.76% | 12,005,530 | -1.83% | 70.19% | 1.37% | 67 | 1.52% | 41 | -2.38% |
| 31 Mar, 22 | 145 | -3.33% | 12,229,169 | 2.82% | 71.50% | 1.47% | 66 | -10.81% | 42 | 13.51% |
| 31 Dec, 21 | 150 | 7.14% | 11,893,607 | 8.75% | 69.66% | 1.61% | 74 | 29.82% | 37 | -5.13% |
| 30 Sep, 21 | 140 | -8.50% | 10,936,360 | -2.39% | 65.72% | 1.44% | 57 | -32.94% | 39 | 2.63% |
| 30 Jun, 21 | 153 | 7.75% | 11,204,474 | -8.06% | 67.61% | 1.14% | 85 | 25.00% | 38 | -5.00% |
| 31 Mar, 21 | 142 | 0.71% | 12,186,285 | -0.43% | 76.93% | 1.23% | 68 | 3.03% | 40 | - |
| 31 Dec, 20 | 141 | 1.44% | 12,239,357 | 5.65% | 79.09% | 1.41% | 66 | 24.53% | 40 | -13.04% |
| 30 Sep, 20 | 139 | 2.96% | 11,585,158 | 2.99% | 74.99% | 1.41% | 53 | -27.40% | 46 | 35.29% |
| 30 Jun, 20 | 135 | 21.62% | 11,249,007 | 2.20% | 72.89% | 1.43% | 73 | 21.67% | 34 | 21.43% |
| 31 Mar, 20 | 111 | -13.95% | 11,006,471 | 5.66% | 71.34% | 1.56% | 60 | -11.76% | 28 | -20.00% |
| 31 Dec, 19 | 129 | 8.40% | 10,416,414 | 8.07% | 67.66% | 1.73% | 68 | 4.62% | 35 | 40.00% |
| 30 Sep, 19 | 119 | -9.85% | 9,638,703 | 0.85% | 62.53% | 1.62% | 65 | -9.72% | 25 | -3.85% |
| 30 Jun, 19 | 132 | -12.58% | 9,556,994 | 1.61% | 62.18% | 1.66% | 72 | -4.00% | 26 | -18.75% |
| 31 Mar, 19 | 151 | 2.72% | 9,405,645 | 10.96% | 61.22% | 2.01% | 75 | 2.74% | 32 | -31.91% |
| 31 Dec, 18 | 147 | -12.50% | 8,476,533 | -1.79% | 55.23% | 1.74% | 73 | -27.00% | 47 | 11.90% |
| 30 Sep, 18 | 168 | 9.09% | 8,630,858 | 6.26% | 56.38% | 1.77% | 100 | -9.09% | 42 | 23.53% |
| 30 Jun, 18 | 154 | 55.56% | 8,122,390 | 28.36% | 56.47% | 2.81% | 110 | 64.18% | 34 | 41.67% |
| 31 Mar, 18 | 99 | 11.24% | 6,327,776 | 23.53% | 44.79% | 2.56% | 67 | -6.94% | 24 | 140.00% |
| 31 Dec, 17 | 89 | 78.00% | 5,122,308 | 91.60% | 41.83% | 8.97% | 72 | 132.26% | 10 | 25.00% |
| 30 Sep, 17 | 50 | 28.21% | 2,673,430 | 30.58% | 21.60% | 7.47% | 31 | - | 8 | 166.67% |
| 30 Jun, 17 | 39 | 50.00% | 2,047,319 | 34.89% | 17.01% | 10.55% | 31 | 93.75% | 3 | - |
| 31 Mar, 17 | 26 | 4.00% | 1,517,802 | 12.79% | 12.70% | 9.29% | 16 | 45.45% | 3 | -25.00% |
| 31 Dec, 16 | 25 | -10.71% | 1,345,660 | 33.60% | 11.69% | 12.61% | 11 | -59.26% | 4 | - |
| 30 Sep, 16 | 28 | - | 1,007,212 | - | 9.63% | - | 27 | - | - | - |
Madrigal Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Madrigal Pharmaceuticals's stock was made by CRAVES FRED B on May 16 2024, selling 8,827 shares at $210.99 per share (valued at $1.86M).
Madrigal Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 17 | 108 | 15.74% |
| Q1 2024 | 20 | 7 | 285.71% |
| Q4 2023 | 150 | 27 | 555.56% |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 10 | 32 | 31.25% |
| Q4 2022 | 1 | 34 | 2.94% |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 6 | 1 | 600.00% |
| Q4 2021 | 1 | 6 | 16.67% |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 1 | 12 | 8.33% |
| Q2 2020 | 6 | 7 | 85.71% |
| Q1 2020 | 4 | 1 | 400.00% |
| Q4 2019 | - | 4 | - |
| Q3 2019 | 1 | - | - |
17 total buy trades, and 108 total sell trades (buy/sell ratio of 0.16%) were made by Madrigal Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 91 | - |
| Q1 2024 | 2 | - | - |
| Q4 2023 | 140 | 16 | 875.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 26 | - |
| Q4 2022 | - | 32 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 6 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 4 | - |
| Q3 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 91 open market sell trades of Madrigal Pharmaceuticals's stocks.
Madrigal Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| PTCT | PTC Therapeutics, Inc. |
| TGTX | TG Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| MREO | Mereo BioPharma Group plc |
| ETNB | 89bio, Inc. |
| VKTX | Viking Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IOVA | Iovance Biotherapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| SRPT | Sarepta Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| KRYS | Krystal Biotech, Inc. |
MDGL Ownership FAQ
Who Owns Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals is owned by institutional shareholders (32.90%), insiders (15.17%), and public (51.93%). The largest institutional shareholder of Madrigal Pharmaceuticals is JANUS HENDERSON GROUP PLC (13.16% of total shares) and the top mutual fund owner is Alger ETF Trust (0.42% of total shares).
Who are the major institutional shareholders of Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals's major institutional shareholders are JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, AVORO CAPITAL ADVISORS LLC, PAULSON & CO. INC., and VANGUARD GROUP INC. The top five shareholders own together 50.40% of the company's share outstanding.
How many Madrigal Pharmaceuticals shareholders are there?
As of Mar 2024, there are 155 institutional shareholders of Madrigal Pharmaceuticals.
What percentage of Madrigal Pharmaceuticals is owned by JANUS HENDERSON GROUP PLC?
JANUS HENDERSON GROUP PLC owns 2.6M shares of Madrigal Pharmaceuticals, representing 13.16% of the company's total shares outstanding, valued at $694.53M (as of Mar 2024).
What percentage of Madrigal Pharmaceuticals is owned by BAKER BROS. ADVISORS LP?
As of Mar 2024, BAKER BROS. ADVISORS LP holds 1.97M shares of Madrigal Pharmaceuticals (MDGL), compromising 9.97% of the company, valued at $526.01M.
What percentage of Madrigal Pharmaceuticals is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC is the third largest holder of Madrigal Pharmaceuticals. The company owns 1.94M of the company's shares outstanding (worth $519.24M).